Osaic Holdings’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Osaic Holdings’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$166	Buy	+1	New	+$164	﹤0.01%	7585
2025 Q2	–	Sell	-5	Closed	-$305	–	7818
2025 Q1	$305	Buy	+5	New	+$426	﹤0.01%	7097
2022 Q4	–	Sell	-85	Closed	-$12K	–	7324
2022 Q3	$12K	Sell	85 -170	-67%	-$31.2K	﹤0.01%	5916
2022 Q2	$34K	Buy	255 +95	+59%	+$16.2K	﹤0.01%	5235
2022 Q1	$50K	Buy	160 +63	+65%	+$23.8K	﹤0.01%	5089
2021 Q4	$70K	Buy	97 +17	+21%	+$16.3K	﹤0.01%	4887
2021 Q3	$88K	Buy	80 +72	+900%	+$88.5K	﹤0.01%	4642
2021 Q2	$11K	Buy	+8	New	+$11.1K	﹤0.01%	6001
2020 Q3	–	Sell	-5	Closed	-$6K	–	6317
2020 Q2	$6K	Buy	+5	New	+$4.34K	﹤0.01%	5402

Other funds holding LABU

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Osaic Holdings's LABU Position: Q1 2026 in Review

Osaic Holdings opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2026: 1 share worth $166. The stake represents ﹤0.01% of the portfolio and ranks #7585 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in LABU as recently as Q1 2025.

Osaic Holdings first reported a position in LABU in Q2 2020 and has held it in 9 quarters since. The position peaked at $88K in Q3 2021. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

Osaic Holdings held 1 share of Direxion Daily S&P Biotech Bull 3X ETF worth $166 as of Q1 2026.
Direxion Daily S&P Biotech Bull 3X ETF was a new Osaic Holdings position in Q1 2026.
Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7585 holding.
Osaic Holdings first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2020 and has held it in 9 quarters since.
Osaic Holdings's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $88K in Q3 2021.
33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.